What is Sutro Biopharma's share buybacks?

Sutro Biopharma (STRO) reported share buybacks of $1.75K in Q4 2021.

What does share buybacks mean?

Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.

Sutro Biopharma STRO Share Buybacks

Share Buybacks at other companies

Gilead SciencesGILD

$419M-42.6%

AnaptysBio, Inc.ANAB

$0-100%

Roivant SciencesROIV

$208.29M-67.9%

BridgeBio PharmaBBIO

$82.5M+70.9%

Other financials

Income statement

See full

Revenue$14.5M-16.5%

Operating income-$29.7M+56.7%

Net income-$38.5M+49.3%

EPS (diluted)-$2.94+67.6%

Balance sheet

See full

Cash & equivalents$73.7M-30.6%

Total debt$13.6M-36.3%

Total equity-$66.9M-159%

Total assets$242.0M-24.7%

Cash flow

See full

Operating cash flow-$42.3M+37.7%

CapEx--100%

Free cash flow-$42.3M+37.8%

Valuation

See full

Market cap$489.66M+624%

Enterprise value$429.61M-2,600%

P/S4.9×+3.9×

Profitability

See full

Operating margin-120%-48.6pp

Net margin-154.2%-56.7pp

FCF margin-152.2%-51.1pp

Returns & leverage

See full

Return on equity-234.2%—

Debt / equity0.5×+0.3×

Current ratio3.1×+1.0×

Where this comes from

Reported directly by Sutro Biopharma in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The official record: Sutro Biopharma’s 10-K, filed March 25, 2024, on SEC EDGAR. View the filing →

Ask your AI about Sutro Biopharma's share buybacks.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Sutro Biopharma's share buybacks?: Sutro Biopharma (STRO) reported share buybacks of $1.75K in Q4 2021.
What does share buybacks mean?: Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.